Formulation of sustained-release microspheres of granulocyte macrophage colony stimulating factor by freezing-induced phase separation with dextran and encapsulation with blended polymers

References

• Andreas K, Zehbe R, Kazubek M, Grzeschik K, Sternberg N, Baumler H, Schubert H, Sittinger M, Ringe J. Biodegradable insulin-loaded PLGA microspheres fabricated by three different emulsification techniques: Investigation for cartilage tissue engineering. Acta Biomater 2011; 7: 1485–95
   PubMed Web of Science ®Google Scholar
• Bertram JP, Saluja SS, McKain J, Lavik EB. Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)/poly(lactic acid) microspheres for over 3 months. J Microencapsul 2009; 26: 18–26
   PubMed Web of Science ®Google Scholar
• Blanco-Príeto MJ, Campanero MA, Besseghir K, Heimgatner F, Gander B. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. J Control Release 2004; 96: 437–48
   PubMed Web of Science ®Google Scholar
• Butler SM, Tracy MA, Tilton RD. Adsorption of serum albumin to thin films of poly(lactide-co-glycolide). J Control Release 1999; 58: 335–47
   PubMedGoogle Scholar
• Castellanos IJ, Carrasquillo KG, López JDJ, Alvarez M, Griebenow K. Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique. J Pharm Pharmacol 2001; 53: 167–78
   PubMed Web of Science ®Google Scholar
• Castellanos IJ, Flores G, Griebenow K. Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation. J Pharm Sci 2006; 95: 849–58
   PubMed Web of Science ®Google Scholar
• Chen L, Apte RN, Cohen S. Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy. J Control Release 1997; 43: 261–72
   Web of Science ®Google Scholar
• Chinese Pharmacopoeia, Vol. III. 2005. Beijing: Chemical Industry Press. Appendix 58–9
   Google Scholar
• Chow AHL, Tong HHY, Zheng Y. Stability assessment and formulation characterization. Handbook of pharmaceutical biotechnology, SC Gad. John Wiley & Sons, Inc., New Jersey 2007; 371–416
   Google Scholar
• Cleland JL. Solvent Evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines. Biotechnol Prog 1998; 14: 102–7
   PubMed Web of Science ®Google Scholar
• Cleland JL, Jones AJS. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharm Res 1996; 13: 1464–75
   PubMed Web of Science ®Google Scholar
• Costantino HR, Johnson OL, Zale SE. Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres. J Pharm Sci 2004; 93: 2624–34
   PubMed Web of Science ®Google Scholar
• Geng Y, Yuan W, Wu F, Chen J, He M, Jin T. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation. J Control Release 2008; 130: 259–65
   PubMed Web of Science ®Google Scholar
• Giteau A, Venier-Julienne MC, Aubert-Pouëssel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles?. Int J Pharm 2008a; 350: 14–26
   PubMed Web of Science ®Google Scholar
• Giteau A, Venier-Julienne M, Marchal S, Courthaudon J, Sergent M, Montero-Menei C, Verdier J, Benoit J. Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres. Eur J Pharm Biopharm 2008b; 70: 127–36
   PubMed Web of Science ®Google Scholar
• Gombotz WR, Pettit DK. Biodegradable polymers for protein and peptide drug delivery. Bioconjugate Chem 1995; 6: 332–51
   PubMed Web of Science ®Google Scholar
• Griebenow K, Klibanov AM. On protein denaturation in aqueous-organic mixtures but not in pure organic solvents. J Am Chem Soc 1996; 118: 11695–700
   Web of Science ®Google Scholar
• Houchin ML, Heppert K, Topp EM. Deamidation, acylation and proteolysis of a model peptide in PLGA films. J Control Release 2006; 112: 111–9
   PubMedGoogle Scholar
• Johansen P, Men Y, Audran R, Corradin G, Merkle HP, Gander B. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm Res 1998; 15: 1103–10
   PubMed Web of Science ®Google Scholar
• Kaiser-Schulz G, Heit A, Quintanilla-Martinez L, Hammerschmidt F, Hess S, Jennen L, Rezaei H, Wagner H, Schatzl HM. Polylactide-coglycolide microspheres coencapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responses. J Immunol 2007; 179: 2797–807
   PubMed Web of Science ®Google Scholar
• Kim HK, Park TG. Microencapsulation of human growth hormone within biodegradable polyester microspheres: Protein aggregation stability and incomplete release mechanism. Biotechnol Bioeng 1999; 65: 659–67
   PubMed Web of Science ®Google Scholar
• Klingemann HG. Clinical applications of recombinant human colony-stimulating factors. CMAJ 1989; 140: 137–42
   PubMed Web of Science ®Google Scholar
• Inc. KPL, 2005. KPLTechnical Note. The use of antibodies in immunoassay. Available at: http://www.kpl.com/docs/techdocs/Antibodies%20in%20Immunoassays.pdf. Accessed 28 February 2011
   Google Scholar
• Lam XM, Duenas ET, Cleland JL. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. J Pharm Sci 2001; 90: 1356–65
   PubMed Web of Science ®Google Scholar
• Lassalle V, Ferreira ML. PLA nano- and microparticles for drug delivery: An overview of the methods of preparation. Macromol Biosci 2007; 7: 767–83
   PubMed Web of Science ®Google Scholar
• Li X, Deng X, Huang Z. In vitro protein release and degradation of poly-dl-lactide-poly(ethylene glycol) microspheres with entrapped human serum albumin: Quantitative evaluation of the factors involved in protein release phases. Pharm Res 2001; 18(1)117–24
   PubMedGoogle Scholar
• Maa YF, Hsu CC. Effect of primary emulsions on microsphere size and protein-loading in the double emulsion process. J Microencapsul 1997; 14: 225–41
   PubMed Web of Science ®Google Scholar
• Mire-Sluis AR, Thorpe R. Laboratory protocols for the quantitation of cytokines by bioassay using cytokine responsive cell lines. J Immunol Methods 1998; 211: 199–210
   PubMed Web of Science ®Google Scholar
• Nemunaitis J, Cox J, Meyer W, Courtney A, Hanson T, Green-Weaver C, Agosti J. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: A Phase II trial. Am J Clin Oncol 1998; 21: 308–12
   PubMedGoogle Scholar
• Pai SS, Tilton RD, Przybycien TM. Poly(ethylene glycol)-modified proteins: Implications for poly(lactide-co-glycolide)-based microsphere delivery. AAPS J 2009; 11(1)88–98
   PubMedGoogle Scholar
• Physicians' Desk Reference, 62 edition. 2008. Montvale: Thomson Healthcare Inc., pp. 806–10
   Google Scholar
• Pollauf EJ, Kim KK, Pack DW. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles. J Pharm Sci 2005; 94: 2013–22
   PubMed Web of Science ®Google Scholar
• Prestrelski SJ, Tedeschi N, Arakawa T, Carpenter JF. Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophys J 1993; 65: 661–71
   PubMed Web of Science ®Google Scholar
• Sánchez A, Villamayor B, Guo Y, McIver J, Alonso MJ. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int J Pharm 1999; 185: 255–66
   PubMed Web of Science ®Google Scholar
• Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76–85
   PubMed Web of Science ®Google Scholar
• Su Z, Sun F, Shi Y, Jiang C, Meng Q, Teng L, Li Y. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere. Chem Pharm Bull 2009; 57: 1251–6
   PubMed Web of Science ®Google Scholar
• Taluja A, Youn YS, Bae YH. Novel approaches in microparticulate PLGA delivery systems encapsulating proteins. J Mater Chem 2007; 17: 4002–14
   Web of Science ®Google Scholar
• Tamilvanan S, Venkatesh Babu R, Kannan K, Basu SK, Sa B. Manufacturing techniques and excipients used druing the design of diodegradable polymer-based microspehres containing therapeutic peptide/protein for parenteral controlled drug delivery. PDA J Pharm Sci Technol 2008; 62: 125–54
   PubMedGoogle Scholar
• van der Walle CF, Sharma G, Ravi Kumar MNV. Current approaches to stabilizing and analysing proteins during microencapsulation in PLGA. Expert Opin Drug Deliv 2009; 6(2)177–86
   PubMed Web of Science ®Google Scholar
• van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic Acid) microparticles. Pharm Res 2000; 17: 1159–67
   PubMed Web of Science ®Google Scholar
• Wadhwa M, Thorpe R. Haematopoietic growth factors and their therapeutic use. Thromb Haemostasis 2008; 99: 863–73
   PubMed Web of Science ®Google Scholar
• Wu F, Jin T. Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances. AAPS PharmSciTech 2008; 9: 1218–29
   PubMed Web of Science ®Google Scholar
• Wu J, Wu L, Xu X, Xu X, Yin X, Chen Y, Hu Y. Microspheres made by w/o/o emulsion method with reduced initial burst for long-term delivery of endostar, a novel recombinant human endostatin. J Pharm Sci 2009; 98: 2051–8
   PubMed Web of Science ®Google Scholar
• Xu Q, Crossley A, Czernuszka J. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres. J Pharm Sci 2009; 98: 2377–89
   PubMed Web of Science ®Google Scholar
• Yang Y, Chung T, Bai X, Chan W. Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem Eng Sci 2000; 55: 2223–36
   Web of Science ®Google Scholar
• Yang Y, Chung T, Ping Ng N. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001; 22: 231–41
   PubMed Web of Science ®Google Scholar
• Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res 2004; 27: 1–12
   PubMed Web of Science ®Google Scholar
• Yoshiura H, Hashida M, Kamiya N, Goto M. Factors affecting protein release behavior from surfactant–protein complexes under physiological conditions. Int J Pharm 2007; 338: 174–9
   PubMedGoogle Scholar
• Yuan W, Geng Y, Wu F, Liu Y, Guo M, Zhao H, Jin T. Preparation of polysaccharide glassy microparticles with stabilization of proteins. Int J Pharm 2009; 366: 154–9
   PubMed Web of Science ®Google Scholar
• Yuan W, Wu F, Geng Y, Xu S, Jin T. Preparation of dextran glassy particles through freezing-induced phase separation. Int J Pharm 2007; 339: 76–83
   PubMed Web of Science ®Google Scholar